Karachi, Abbott Laboratories (Pakistan) Ltd. (ABOT), a leading name in the pharmaceuticals industry since 1982, reported an earnings per share (EPS) of Rs. 30.69* for the fiscal year ending January 2024. The company declared a 150% dividend, showcasing its robust financial health and commitment to delivering value to shareholders. With a share rate of Rs. 402.00 and a paid-up capital, Abbott Laboratories continues to set high standards in the healthcare sector.